# RYSTIGGO

NDC: 50474-982
Generic name: ROZANOLIXIZUMAB
Labeler / Manufacturer: UCB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20240614

FDA application: BLA761286

## Active ingredients

- ROZANOLIXIZUMAB: 140 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50474-982"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50474-982
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c0eb8c2-c042-4954-b451-3baa77f5e6d1